Stay updated on Pembrolizumab for Genomic Instability Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page
- Check4 days agoChange DetectedUpdated the document revision from v3.5.4 to v3.5.5 in the Study Plan documents. This indicates a newer version of the protocol and SAP is now referenced on the page.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page shows a revision update from v3.5.3 to v3.5.4, indicating a minor page update; no changes to the study data or eligibility criteria are indicated.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s displayed revision/version number has been bumped from v3.5.2 to v3.5.3, reflecting a website release update rather than a change to the study content.SummaryDifference0.1%

- Check54 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check68 days agoChange DetectedStudy status updated to Active, not recruiting and results posted with related documentation (Results First Submitted/Posted) and dates. ORR outcome measure details are added to the Results section.SummaryDifference4%

- Check83 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a minor front-end update with no visible changes to the study details or related content.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.